Research

Apple delivered broad-based Q3 growth, with revenue up 16.4% and EPS up 28.7%. Tariff refunds helped margins, while the current price already reflects much of the improvement.

AbbVie delivered higher revenue, EPS and operating margins in Q2 FY2026. The print supports operating momentum, but our $251.6 fair value is close to the market price.

Abbott’s revenue held near the prior-year level, but operating margin and EPS declined sharply. Cash generation remains supportive, leaving the shares near fair value rather than clearly inexpensive.

Accenture delivered higher revenue, EPS and operating margin in fiscal Q3. A $210 base-case value implies upside, though limited disclosure constrains conviction.

Adobe's growth accelerated and management raised FY2026 targets as AI-first ARR topped $500 million. Lower GAAP margin and slightly weaker free cash flow temper the result.